|
|
|
|
|
by mdup
3868 days ago
|
|
I remember reading in another HN thread about insulins (too lazy to search it right now) that plenty of prototype insulins have been developed, but most of them could cause nasty diseases, notably cancer. Hence only a low number of well-tested commercial insulins have been pushed to the market. Does someone knowledgeable have more info about those "good" vs. "bad" insulins? |
|
once these disulfide linkages are created, this insulin precursor undergoes a multi step enzymatic cleavage which cuts off some bits and makes biologically active insulin.
There are many ways to create insulin synthetically, and some of them lead to product contaminated with misfolded proteins. Misfolded proteins may have no effect, but sometimes they can activate the IGF-1 signal pathway which has been associated with cancer. There is also a chance of an autoimmmune reaction to the misfolded insulin, which would also be very bad.
We are exploring a few different methods for our insulin production specifically with this concern in mind.